Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure
NCT ID: NCT04062500
Last Updated: 2020-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10500 participants
OBSERVATIONAL
2018-01-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
China National Heart Failure Registry
NCT02079428
Study of China Heart Failure Registry to Investigate Characteristics of Patients in China
NCT02664818
Heart Failure Treatment Pattern Analysis of HF Patients in HF Centers and Non-HF Centers in China
NCT06099028
Hospital-Community-Family-Care Management Platform for Chronic Heart Failure
NCT02029287
Evaluation of Clinical and Genetic Modifiers of Long-term Survival in Heart Failure
NCT03461107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To elucidate the clinical characteristics and prognostic risks of patients with heart failure.
2. To study the characteristics of high-risk heart failure patients and predict the key factors for the development of symptomatic heart failure patients.
3. To elucidate the compliance of patients with heart failure and the incidence of adverse drug effects.
4. To investigate the effect of self-management on outcomes in patients with heart failure.
5. To elucidate critical factors associated with the development and outcomes of heart failure.
6. To investigate hospitalization expenses for heart failure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with heart failure
patients treated in the hospital for acute heart failure in China
Mortality and Rehospitalization rate
Mortality and Re-hospitalization of acute decompensated heart failure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mortality and Rehospitalization rate
Mortality and Re-hospitalization of acute decompensated heart failure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
3\. Agree to be tested and sign an informed consent certificate.
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital, Sun Yat-Sen University
OTHER
Nanfang Hospital, Southern Medical University
OTHER
Beijing Chao Yang Hospital
OTHER
First Hospital of China Medical University
OTHER
Yangpu District Central Hospital Affiliated to Tongji University
OTHER
Xuhui Central Hospital, Shanghai
OTHER
Ningbo Medical Center Lihuili Hospital
OTHER_GOV
Shaanxi University of Chinese Medicine
OTHER
People's Hospital of Xinjiang Uygur Autonomous Region
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
Shanghai 10th People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ya-Wei Xu
MD, pHD, Director of Cardiovascular Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dachun Xu, PhD
Role: PRINCIPAL_INVESTIGATOR
Shanghai Tenthth People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Tenth People's Hospital, Tongji University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Su Y, Ma M, Zhang H, Pan X, Zhang X, Zhang F, Lv Y, Yan C. Prognostic value of serum hyponatremia for outcomes in patients with heart failure with preserved ejection fraction: An observational cohort study. Exp Ther Med. 2020 Nov;20(5):101. doi: 10.3892/etm.2020.9231. Epub 2020 Sep 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GREARTWAL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.